TipRanks
Attovia Therapeutics, Inc. (ATTO)
NASDAQ:ATTO
US Market
ATTO
Attovia Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see ATTO full AI Analyst Report?

Attovia Therapeutics, Inc. (ATTO) Income Statement

13 Followers

Attovia Therapeutics, Inc. Income Statement

Last quarter (Q2 2026), Attovia Therapeutics, Inc.'s total revenue was $450.00K, a decrease of -99.87% from the same quarter last year. In Q2, Attovia Therapeutics, Inc.'s net income was $-20.69M. See Attovia Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 21Dec 20Dec 19
Total Revenue
$ 1.35M$ 0.00$ 1.45B$ 1.41B$ 1.71B
Gross Profit
$ 546.00K$ -313.00K$ 1.36B$ 1.34B$ 1.64B
Operating Expenses
$ 67.70M$ 41.24M$ 1.34B$ 1.30B$ 1.61B
Depreciation and Amortization
$ 804.00K$ 313.00K$ 133.20M$ 120.90M$ 140.80M
EBITDA
$ -66.36M$ -41.24M$ 232.70M$ 176.90M$ 204.40M
Operating Income
$ -67.16M$ -41.55M$ 72.50M$ 56.00M$ 63.60M
Other Income/Expenses
$ 6.53M$ 1.75M$ -156.90M$ -82.00M$ -57.10M
Pretax Income
$ -60.63M$ -39.80M$ -84.40M$ -41.70M$ -44.50M
Net Income
$ -60.63M$ -39.80M$ -90.20M$ -46.80M$ -80.70M
Per Share Metrics
Basic EPS
$ -1.42$ -1.05$ -6.41$ -3.32$ -5.59
Diluted EPS
$ -1.42$ -1.05$ -6.41$ -3.32$ -5.59
Weighted Average Shares Outstanding
 43.03M 43.03M 14.06M 14.08M 14.45M
Weighted Average Shares Outstanding (Diluted)
 43.03M 43.03M 14.06M 14.08M 14.45M
Currency in USD

Attovia Therapeutics, Inc. Earnings and Revenue History